DIN 02519011 — BLEXTEN 2.5 MG
BLEXTEN is a solution of Bilastine marketed by ARALEZ PHARMACEUTICALS CANADA INC. The full Bilastine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02519011
- Brand name
- BLEXTEN
- Active ingredient
- Bilastine
- Strength
- 2.5 MG
- Dosage form
- SOLUTION
- Route
- ORAL
- Manufacturer
- ARALEZ PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Second-generation (non-sedating) H1-antihistamine
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Bilastine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02549883 | APO-BILASTINE TABLETS | 20 MG | TABLET | APOTEX INC | MARKETED |
| 02541556 | AURO-BILASTINE | 20 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02519038 | BLEXTEN | 10 MG | TABLET (ORALLY-DISINTEGRATING) | ARALEZ PHARMACEUTICALS CANADA INC | MARKETED |
| 02454130 | BLEXTEN | 20 MG | TABLET | ARALEZ PHARMACEUTICALS CANADA INC | MARKETED |
| 02544369 | GLN-BILASTINE | 20 MG | TABLET | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED |
| 02546795 | JAMP BILASTINE | 20 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02448262 | JAMP BILASTINE ORAL SOLUTION | 2.5 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02548410 | M-BILASTINE | 20 MG | TABLET | MANTRA PHARMA INC | MARKETED |
| 02547279 | MAR-BILASTINE | 20 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED |
| 02551934 | NRA-BILASTINE | 20 MG | TABLET | NORA PHARMA INC | MARKETED |
| 02561565 | PMS-BILASTINE | 20 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02536269 | SANDOZ BILASTINE | 20 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |